It helps regulate blood glucose, slows digestion, and signals fullness to the brain
The efficacy of these treatments is limited, with inconsistent impact on fibroid size and bleeding, and their use is often limited in time due to their safety profile
More recently, long-acting GLP-1 RAs for obesity have been approved: semaglutide (approved in 2021), resulted in an average weight reduction of around 15% 1214 , and tirzepatide (approved in 2023), demonstrating an average weight reduction of approximately 20% 1517
Many people achieve the desired weight loss and then go on a healthy maintenance program. In addition to the weight loss program and the peptide therapy program, MD Aesthetics provides a full array of aesthetic services such as skin care, laser technology, and micro needling